| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |